Volume change rate ranking (9:00) - Shima Chemical, Ribomic, etc. are ranked.
*In the volume change rate ranking, you can understand the interest of market participants such as trends in hunting by comparing the average volume of the past 5 days with the volume on the day of delivery.
Volume change rate ranking (2pm) - Medrex, Aeon, etc. ranked in
In the volume change rate ranking, you can understand the market participants' interest in trends such as market searches by comparing the average volume over the past 5 days with the volume on the day of delivery. ■ Volume change rate top [as of 14:32 on September 6] (comparison of average volume over the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Price change rate ＜7271＞ Yasunaga 712,600 97,107.08 268.83% 0.0586%
Volume change rate ranking (10 o'clock) - Sumitomo House, Medrex, etc. are ranked.
※In the volume change rate ranking, you can understand the market participants' interest in trends, such as stock picking, by comparing the average volume of the last 5 days with the volume on the delivery day. ■ Volume Change Rate Top [As of September 6, 10:32] (Comparison of the average volume of the last 5 days) Stock code Stock name Volume 5-day average volume Volume Change Rate Stock Price Change Rate <4586> Medorex 4966000 73731.02 231.2% 0.0297
Volume change rate ranking (9:00) - Rockfield, Kikukawa, etc. are ranked.
In the volume change rate ranking, by comparing the volume in the last 5 days with the volume on the day of delivery, you can understand the market participants' interest in trends and other things. Top volume change rate [As of September 6th, 9:32] (comparing the volume in the last 5 days): Stock code, Stock name, Volume, 5-day average volume, Volume change rate, Stock price change rate: <6396> Unotech, 15,400, 107,185.08, 378.47%, -0.1569
Takara Leben Real Estate Investment: Supplementary explanatory materials on the 6th public offering and assets to be acquired
Takara Leben Real Estate Investment: Notice regarding revisions to operating status and dividend forecasts for the fiscal year ending 2025/2, and operating status and distribution forecasts for the fiscal year ending 2025/8